Growth Metrics

Haemonetics (HAE) Depreciation and Depletion (2018 - 2025)

Haemonetics has reported Depreciation and Depletion over the past 5 years, most recently at $14.9 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 1.97% year-over-year to $14.9 million; the TTM value through Dec 2025 reached $61.0 million, up 2.52%, while the annual FY2025 figure was $60.0 million, 7.53% up from the prior year.
  • Depreciation and Depletion for Q4 2025 was $14.9 million at Haemonetics, down from $15.5 million in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $15.5 million in Q3 2025 and troughed at $11.7 million in Q3 2022.
  • A 4-year average of $14.2 million and a median of $14.6 million in 2024 define the central range for Depreciation and Depletion.
  • Biggest five-year swings in Depreciation and Depletion: rose 13.68% in 2023 and later dropped 1.97% in 2025.
  • Year by year, Depreciation and Depletion stood at $13.1 million in 2022, then increased by 8.4% to $14.2 million in 2023, then rose by 7.04% to $15.2 million in 2024, then decreased by 1.97% to $14.9 million in 2025.
  • Business Quant data shows Depreciation and Depletion for HAE at $14.9 million in Q4 2025, $15.5 million in Q3 2025, and $15.4 million in Q2 2025.